When conservative treatments fail for 3 to 6 months, decompressive surgery is usually considered. The most recent Cochrane review concluded that there was only heterogeneous and limited evidence on its effectiveness, but it was issued in 2005. 19 Therefore, the objectives of this study were to: (1) systematically review the evidence on the effectiveness and safety of any form of surgery versus conservative treatment for symptomatic lumbar spinal stenosis, and (2) explore whether available data made it possible to refi ne indication criteria for either type of treatment, on the basis of the existence of spondylolisthesis or neurogenic claudication.
MATERIALS AND METHODS

Search and Study Selection
An electronic search was performed in CENTRAL (Cochrane library 2009, issue 2), MEDLINE (January 1966-July 2009), EMBASE (January 1980-July 2009), and on the Internet through TripDatabase (only for reviews and technical reports). The terms "spinal stenosis," "lumbar stenosis," "claudication," "spinal stenos," "surgery or surgical," and "low back pain, lumbago, back pain or backache" were combined with the highly sensitive search strategy to identify randomized controlled trials (RCTs) developed by the Cochrane Collaboration. 20 Studies were included in this review if they were RCTs providing data on the comparison of the effectiveness or safety of any surgical procedure with any form of conservative treatment in patients with neurogenic claudication or sciatica, and lumbar spinal stenosis that had been confi rmed by imaging. No language restriction was applied.
References identifi ed were retrieved and assessed independently by two authors (G.U. and J.D.A.) to check for inclusion criteria. Disagreements were solved by consensus with the third author (F.M.K.).
For studies that included randomized and nonrandomized cohorts, this review considered data only from the randomized cohort to compare the effectiveness of surgical and conservative treatments, although adverse events from all patients were gathered. Separate data were also requested from the authors with regard to patients with and without spondylolisthesis, and neurogenic claudication.
Quality Assessment and Data Analysis
Methodological quality of each study was independently assessed by two of the three reviewers (G.U., J.D.A., and F.M.K.), following the criteria recommended by the Cochrane Back Review Group. 21 , 22 Criteria on blindness of patients and therapists were disregarded because they were not applicable when comparing surgery with conservative treatment ( Table 1 ). Therefore, the maximum possible score was 9 points and a study was considered as being of "high quality" if it scored 5 points or more.
Data extraction was independently undertaken (G.U. and J.D.A.). Disagreements in quality assessment and data extraction were solved by consensus (G.U., J.D.A., and F.M.K.). Despite what was planned at the design phase, neither a quantitative synthesis of data nor a sensitivity analysis was possible because of the variability of outcome measures and the heterogeneity of the methods used across the studies ( Table 2 ) . Therefore, a qualitative analysis of data was performed on the basis of the methodological quality of included trials and the consistency of their fi ndings.
RESULTS
The electronic search identifi ed 739 references. A total of 30 publications, corresponding to 17 studies were identifi ed as eligible. Ten publications (nine studies) were excluded because they did not focus on spinal stenosis, 28 -37 eight publications (two studies) because they were not randomized, 38 -45 and one publication because it mixed patients who had and had not been randomized, and the authors were not able to provide their data separately. 46 The remaining 11 publications (fi ve studies) were included in this review. 23 -27 , 47 -52 For the purpose of this review, individual studies are identifi ed by using the fi rst publications reporting primary clinical endpoints. 23 -26 , 50 Three of these studies included data from both observational and randomized coho rts, 23 , 25 , 26 but they were included because the authors provided separate data for those patients in the randomized cohorts. 25 , 26 All studies scored as being of high quality, although the sample size of one of them was very small. 23 Most outcomes were self-reported by the patients and blinding of care providers and patients was not feasible. Hence, outcome assessment was not blinded ( Table 1 ) .
The mean age of patients included in the studies ranged between 62 and 70 years. Imaging had documented spinal stenosis in all the participants. One study included only patients with spondylolisthesis, 25 one included only patients without spondylolisthesis, 26 one included only patients with spondylolisthesis of grade I and lesser, 50 and the other two included patients both with and without spondylolisthesis. 23 , 24 When contacted, the authors from the two latter studies were unable to provide separate data for patients with and without this radiological fi nding ( Table 2 ) .
One study included only patients with neurogenic claudication, 50 whereas the other four included patients with pain radiating down to the leg, both with and without neurogenic claudication. 23 -26 The authors from two of these studies were able to provide separate data for patients with and without neurogenic claudication. 25 , 26 Most patients included in the other two studies reported neurogenic claudication, 23 , 24 although separate data on their evolution were not available ( Table 2 ) .
Four studies assessed the effectiveness of decompressive surgery (laminectomy, medial facetectomy, discectomy, and/ or removal of osteophytes and hypertrophic ligament fl ava) with or without instrumented or noninstrumented fusion. All patients were analyzed in their original group regardless of the actual treatment received. Dropouts during case followup were assumed to be negligible. The primary analysis was performed according to the "intention to treat" principle.
In addition, an "as treated" analysis (adjusted for potential confounding factors) was also performed to study the potential effects of crossovers.
Same as in Weinstein et al 25 .
Outcomes from patients who withdrew from the study (7 in the surgery group and 19 in the control group) were not included in the results. by the industry, as opposed to public or not-for-profi t sources, in which at least one author had potentially relevant confl ict of interest. 50 Treatments in the conservative arms of those studies included different or nonspecifi ed types of orthosis, rehabilitation, physical therapy, exercise, nonsteroidal anti-infl ammatory drugs, analgesics, and education, as well as heat and cold, transcutaneous electrical nerve stimulation, ultrasound, and epidural steroids.
The decision on the kind of surgery or conservative treatment applied to each patient was left up to the therapists and no explicit criteria were used.
Follow-up ranged between 2 and 10 years. Variables that were assessed during follow-up included pain, function, claudication distance, quality of life, and patients' overall rating and satisfaction, although instruments used to assess those variables varied across studies ( Table 3 ) . Disability, as measured by the Oswestry Disability Index at 2 years, was the only outcome that was assessed in 3 studies or more ( Figure 1 ). 24 -26 Losses to follow-up ranged between 7.7% (at 1 year) and 44.0% (at 4 years), and were roughly similar between the surgical and conservative arms ( Table 2 ) .
Small improvements were generally seen in the patients treated conservatively and in whom no catastrophic complications such as cauda equina syndrome arose. Changes in claudication distance were similar between conservative and surgical groups. 24 However, results of all the studies consistently favored decompressive surgery (with or without fusion) for improvement of pain, function, and quality of life, as well as in terms of patients' satisfaction. 23 -26 Crossover rates ranged between 9% and 54%, and affected patients assigned to both the conservative and surgical groups ( Table 3 ) . In the two studies with higher crossover rates, 25 , 26 differences between conservative and surgical treatments were statistically signifi cant only in the "as treated" analysis. The only exception was 36-item Medical Outcomes Study Short-Form General Health Survey (SF-36)-"bodily pain," which even in the "intention to treat" analysis favored surgery at 2 years in one of these studies. 26 The advantage of surgery was already noticeable at 3 to 6 months and remained constant for up to 2 to 4 years, although by the end of that period the differences tended to be smaller ( Table 3 ). In general, the magnitude of the additional improvement triggered by surgery in pain and function was clinically relevant. 53 , 54 Surgery was more effective than conservative treatment for patients with and without spondylolisthesis. Surgery was also more effective than conservative treatment for patients with and without neurogenic claudication, although the advantage of surgery was generally greater for the former ( Table 3 ) .
The interspinous implant also led to a better evolution than conservative treatment with regard to pain, function, quality of life, and patients' satisfaction.
27 , 50 -52 Differences were statistically signifi cant at 6 weeks and remained so till 2 years later. Results favored the implant over conservative treatment to the same extent in patients with and without (Grade I) spondylolisthesis. This radiological feature was not predictive of outcome. 
LITERATURE REVIEW
In patients aged 50 years or older with neurogenic claudication and spondylolisthesis of Grade I who are able to walk 50 feet or more and have no motor defi cit, the implantation of a specifi c type of interspinous distraction device also leads to better results than conservative treatment for up to 2 years. 27 Results beyond this time period are unknown. The evidence supporting these results derives from industry-funded studies whose authors harbored confl icts of interests. 27 The effectiveness or safety of other interspinous implants is unknown and no study has directly compared decompressive surgery with the interspinous implant.
Only among patients who have spondylolisthesis, adding fusion to decompression may improve the results of surgery for lumbar spinal stenosis. 58 -60 However, fusion increases major complications, 30-day mortality, and resources used. 55 In patients who have fusion, instrumented and noninstrumented fusion lead to similar results. 27 , 61 , 62 Among patients who undergo instrumented fusion, simpler procedures ( i.e ., anterior or transverse process or posterior fusion, at only 1 or 2 levels) are safer than complex ones ( i.e. , any combination of simple procedures, 360º fusion, or fusion of more than two levels) 19 , 55 , 62 -64 and lead to similar results. 61 In all the studies included in this review, each care provider decided the form of conservative or surgical treatment applied to a given patient without following any predefi ned indication criteria. This approach was probably the only feasible one, but it led to treatments within the conservative and surgical groups being as heterogeneous as they are in routine practice both across studies and across patients in the same study. This precludes any conclusion on the comparative effectiveness of any particular form of surgery or conservative treatment. However, surgery was more effective than conservative treatment across all the studies and results of surgery were roughly consistent among different surgeons in trials conducted in the United States and Scandinavia. This may suggest that their criteria were somehow consistent or that potential differences in their criteria or in the different surgical techniques used do not have a signifi cant infl uence on results.
Data from observational or nonrandomized cohorts were excluded from this review because of concerns regarding the risk of unknown biases. However, despite being classifi ed as "high quality" according to methodological criteria, 21 , 22 concerns exist with regard to the studies included in this review. One study recruited only 31 patients, 23 another included only 94, 24 and none conducted a power analysis. As a result, sample sizes may have been insuffi cient to detect differences for some outcomes. Treatments used in both the surgical and conservative groups were heterogeneous and were not selected according to explicit criteria. To be eligible, patients had to have previously undergone conservative treatment unsuccessfully, which may have made it diffi cult to recruit large samples, affected the comparability of the unspecifi c effects across groups ( e.g ., Hawthorne or placebo), and increased rates of withdrawal, dropout, and crossover. 23 , 25 , 26 Although results consistently favored surgery, in the two studies with Adverse events among patients treated conservatively included injection intolerance, symptom fl are, leg paresthesia, and increased back pain. Among patients who underwent decompressive surgery, with or without spinal fusion, between 5.4% and 14% suffered from perioperative complications (the most common being, in all studies, dural tears). Postoperative complications arose in between 8.2% and 18% of the patients and included pulmonary edema, peridural hematoma, sepsis, and misjudgment of stenotic level. Reported reoperation rates were 1.3% to 2% at 1 year, 6% to 11% at 2 years, and 15% at 4 years. The rate of recurrent stenosis at 4 years was 5%. The mean duration of the operation was 120 to 199 minutes and the mean blood loss was 198 to 589 mL. 25 , 26 The number of deaths were similar in the surgical and conservative groups. The overall postoperative death rate ranged between 0.3% and 0.5%. Approximately 90% of the patients undergoing surgery did not suffer from any adverse event.
Adverse events related to the implantation of the interspinous distraction device included asymptomatic spinous process fracture (1%), malpositioned implant (1%), implant dislodgement or migration (1%), increased pain at implant level (1%), wound dehiscence (1%), wound swelling (1%), incisional pain (1%), and hematoma (1%). In addition, one patient suffered from respiratory distress, another from a transient ischemic coronary episode, and a patient with a history of cardiovascular disease died from pulmonary edema 2 days after device implantation. The reported mean blood loss was 46 mL, the mean duration of the procedure was 54 minutes, and 96% of the patients stayed in the hospital for less than 24 hours. Among the patients in whom the interspinous distraction device was implanted, 7% subsequently underwent a laminectomy. Among those with spondylolisthesis, this percentage was 11.9%.
DISCUSSION
These results suggest that in patients with radicular pain caused by spinal stenosis, in whom conservative treatment has failed for 3 to 6 months, decompressive surgery (with or without fusion) does not improve walking ability but improves pain, function, and quality of life to a greater extent than continuing conservative treatment. Surgery is superior to conservative treatment irrespective of the patients' degree of affectation whether they have spondylolisthesis or neurogenic claudication. However, slightly better results for surgery can be anticipated in patients with neurogenic claudication. Patients should be aware that the benefi ts of surgery decrease with time but still remain signifi cant till 4 (and possibly 10) years later. 23 , 49 Results in the longer term are unknown. However, obtaining a clinically relevant improvement for such a period is worthwhile even if it were to fade thereafter.
Surgery for spinal stenosis can be effective despite advanced age, multilevel involvement, or common comorbidities such as diabetes, obesity, chronic coronary disease, or chronic lung diseases. 26 , 55 -57 However, these features, especially the latter, and hospitalizations in the previous year are associated with more complications and mortality. 55 Therefore, the risks of are not present, decompressive surgery could be envisaged. In patients with signifi cant spondylolisthesis, the surgeon may consider complementing decompressive surgery with noninstrumented posterolateral fusion or with the simplest possible instrumented fusion procedure. This approach would not be suitable for patients who show spinal stenosis on imaging but are asymptomatic or report only back pain (without pain or neurological symptoms in the legs), or for those with serious neurological impairment, especially in those with cauda equina syndrome in whom surgery should be conducted urgently. 67 Generalizability of these results to clinical practice should be discussed. Care providers participating in these RCTs were volunteers as opposed to a random selection of those working in the setting where the studies took place and whether their criteria and level of skills are representative of the rest of care providers in their environment is unknown. Moreover, no data are available on the learning curves necessary before application of some of the forms of treatment that were used in these studies, such as epidural injections or surgery. Education and training standards for these procedures in routine practice should match those required in these RCTs because these standards are essential for generalizability of any nonpharmacological health technology. 66 Postmarketing surveillance should also be implemented, ideally by setting up a registry including all patients seeking care for symptomatic spinal stenosis, minimizing losses to follow-up, and using validated methods to gather clinically relevant data (including demographic data, clinical features, comorbidities, conservative and surgical treatments applied to each patient, experience and training standards of the care providers applying them, and patient's clinical evolution). 66 Such postmarketing surveillance would not substitute RCTs but would be valuable to: (1) determine the effects in routine clinical practice, of treatments that have previously shown to be effective through RCTs, (2) compare, in routine practice conditions, the results from treatments that have shown to be effective for the same subset of patients as in previous RCTs, (3) identify factors that predict the result of each treatment to refi ne its indication criteria, and (4) gather data on unexpected safety concerns.
In conclusion, this review shows that decompressive surgery with or without fusion and implantation of a specifi c interspinous distraction device are more effective than continued conservative treatment for radicular pain due to spinal stenosis in patients in whom the latter has failed for 3 to 6 months. the largest crossover rates, most differences were statistically signifi cant only in the "as treated" analysis and not in the "intention to treat" one. 25 , 26 Moreover, blindness (of therapists, patients, and outcome assessors) is unfeasible in studies comparing surgical with nonsurgical procedures and the placebo effect from surgery is likely to be more powerful than the one from conservative treatment, especially among patients in whom the latter has already failed. This is a special concern because outcome variables are subjective and assessed by the patients ( e.g ., pain severity, function, and satisfaction).
However, these are the variables that make clinical sense, were assessed using previously validated methods, the studies' design was reasonable ( Table 1 ) , and their limitations are inherent to the kind of treatments being assessed and to the patient characteristics. The only way of controlling for potential differences in the placebo effect would be to undertake RCTs comparing decompressive surgery with sham surgery, which might face ethical and practical diffi culties. Despite differences in methods and geographical settings, results from the studies included in this review consistently favor surgery and are biologically plausible. All this suggests that, although methodological weaknesses make it inappropriate to consider each of the reviewed studies as representing "the best evidence in ideal conditions," the general conclusions from this review may be seen as deriving from "the best possible evidence in this fi eld." Further RCTs could also compare different surgical techniques in specifi c subsets of patients and should compare the interspinous device with surgery in the subset of patients in whom the former is indicated. Such a study appears to have been initiated. 65 Further RCTs could also assess the effectiveness of specifi c forms or combinations of conservative treatments to compare surgery with truly effective alternatives. All these studies should be of high methodological quality and conducted independently from the industry by authors with no confl icts of interest. 66 They should be designed as large multicenter trials with strategies to reduce withdrawals and crossovers. There may be ethical concerns regarding further RCTs using the same methods as those used in the studies included in this review to compare the same miscellanea of surgical and conservative treatments.
No catastrophic events ( e.g ., cauda equina syndrome) arose among the patients receiving conservative treatment. Results from surgery were similar among patients initially assigned to surgery and those who crossed over to this group after failure of the conservative treatment they had been initially assigned to. 23 , 25 , 26 This suggests that delaying surgery is not associated with a poorer prognosis. On the contrary, the interspinous implant is less aggressive and resulted in less blood loss and a shorter hospital stay than decompressive surgery (with or without fusion). Taken together, these results may counsel a step-by-step approach in the treatment of spinal stenosis. The fi rst step could be a conservative treatment for 3 to 6 months. If such an approach fails, the implantation of a specifi c type of inerspinous device should be considered in patients aged 50 years and older, with neurogenic claudication and spondylolisthesis of Grade I or less who are able to walk 50 feet or more and have no motor defi cit. If these indication criteria
➢ Key Points
Five high-quality randomized controlled trials (RCTs), including a total of 918 patients, compared surgical procedures (the implantation of a specifi c type of interspinous distraction device or decompressive surgery, with or without fusion, whether instrumented or not) with a miscellanea of conservative treatments, in patients with symptomatic lumbar spinal stenosis in whom the latter had failed for 3 to 6 months.
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In all the studies, surgery led to better results for pain, disability, and quality of life, although not for walking ability. Results of surgery were similar among patients with and without spondylolisthesis, and slightly better among those with neurogenic claudication than among those without it. The advantage of surgery was noticeable at 3 to 6 months and remained for up to 2 to 4 years, although at the end of that period diff erences tended to be smaller. Main methodological concerns in these RCTs include the heterogeneity of treatments within the conservative and surgical groups, the fact that all patients included had unsuccessfully undergone conservative treatments previously, which may have led to diff erences in the placebo eff ect across groups and increased crossover, withdrawal, and dropout rates, and the lack of blindness of care provider, patients, and outcome assessment. However, these concerns are inherent to the type of patients included and the kind of treatments compared. Therefore, evidence from these RCTs can be seen as the "best possible" in this fi eld. There may be ethical concerns regarding further RCTs comparing the forms of surgery and conservative treatments, which have been used in these trials. Further RCTs should: (1) compare the interspinous device with surgery in patients aged 50 years or older, with neurogenic claudication and spondylolisthesis of Grade I and lesser, who are able to walk 50 feet or more, and have no motor defi cit; (2) compare different surgical techniques and interspinous devices in specifi c subsets of patients; (3) defi ne indication criteria for the diff erent surgical procedures; (4) defi ne learning curves for all these procedures; (5) implement registries and postmarketing surveillance methods; and (6) not be conducted by the industry or by authors who harbor confl icts of interest.
